July 30, 2023

Biogen’s $7.3B M&A deal, layoffs; R&D shakeup at Pfizer, AstraZeneca; Scaling rare disease meds; Q2 earnings; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

Amber Tong July 30, 2023

Pharma

Why Was Bronny James in the ICU This Week?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

FHS July 30, 2023

Pharma

IQ After Pediatric Concussion; Hearing Aids and Dementia Progression

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

FHS July 30, 2023

Pharma

Opinion | Challenges in Developing Long COVID Criteria

Jason is a psychology professor and community researcher. Hansel is a research assistant. In a recent JAMA article, researchers provided a new approach for identifying

FHS July 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

July 30, 2023

Biogen’s $7.3B M&A deal, layoffs; R&D shakeup at Pfizer, AstraZeneca; Scaling rare disease meds; Q2 earnings; and more

Why Was Bronny James in the ICU This Week?

IQ After Pediatric Concussion; Hearing Aids and Dementia Progression

Opinion | Challenges in Developing Long COVID Criteria

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe